Journal of Cardiovascular Pharmacology : Impact Factor & More
eISSN: 1533-4023pISSN: 0160-2446
Share this on:
Key Metrics
CiteScore 
3.7
Impact Factor
< 5
SNIP
0.8
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Journal of Cardiovascular Pharmacology
Journal of Cardiovascular Pharmacology Journal Specifications
| Overview | |
| Publisher | LIPPINCOTT WILLIAMS & WILKINS |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1979 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Journal of Cardiovascular Pharmacology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Journal of Cardiovascular Pharmacology
ApoC-III Inhibition in Hypertriglyceridemia: From Triglyceride Lowering to Clinical Risk Modification.
- 7 Aug 2026
- Journal of cardiovascular pharmacology
Effect of EET-A treatment on Cardiac Hypertrophy Induced by Isoproterenol in Sprague-Dawley Rats.
- 7 Aug 2026
- Journal of cardiovascular pharmacology
Cardiovascular Adverse Events Associated With Immune Checkpoint Inhibitors From the Perspective of Gut Microecology: Potential Roles and Research Advances of the Gut Microbiota.
- 1 Aug 2026
- Journal of cardiovascular pharmacology
GLP-1 Gene Therapy Trial for Obesity and Type 2 Diabetes: Toward a New Paradigm for Chronic Disease Treatment.
- 1 Aug 2026
- Journal of cardiovascular pharmacology
Ivabradine in the Treatment of POTS Before and After COVID-19 Pandemic: A Systematic Review and Meta-Analysis.
- 1 Aug 2026
- Journal of cardiovascular pharmacology
Silencing Triglycerides: The Clinical Impact of Plozasiran and apoC-III Inhibition in Severe Hypertriglyceridemia.
- 1 Aug 2026
- Journal of cardiovascular pharmacology
ApoC-III Inhibition in Hypertriglyceridemia: From Triglyceride Lowering to Clinical Risk Modification.
- 7 Aug 2026
- Journal of cardiovascular pharmacology
Effect of EET-A treatment on Cardiac Hypertrophy Induced by Isoproterenol in Sprague-Dawley Rats.
- 7 Aug 2026
- Journal of cardiovascular pharmacology
Cardiovascular Adverse Events Associated With Immune Checkpoint Inhibitors From the Perspective of Gut Microecology: Potential Roles and Research Advances of the Gut Microbiota.
- 1 Aug 2026
- Journal of cardiovascular pharmacology
GLP-1 Gene Therapy Trial for Obesity and Type 2 Diabetes: Toward a New Paradigm for Chronic Disease Treatment.
- 1 Aug 2026
- Journal of cardiovascular pharmacology
Ivabradine in the Treatment of POTS Before and After COVID-19 Pandemic: A Systematic Review and Meta-Analysis.
- 1 Aug 2026
- Journal of cardiovascular pharmacology
Silencing Triglycerides: The Clinical Impact of Plozasiran and apoC-III Inhibition in Severe Hypertriglyceridemia.
- 1 Aug 2026
- Journal of cardiovascular pharmacology
FAQs on Journal of Cardiovascular Pharmacology
How long has Journal of Cardiovascular Pharmacology been actively publishing? 
What is the publishing frequency of Journal of Cardiovascular Pharmacology?
How many articles did Journal of Cardiovascular Pharmacology publish last year?
What is the eISSN & pISSN for Journal of Cardiovascular Pharmacology?
What is Citescore for Journal of Cardiovascular Pharmacology?
What is SNIP score for Journal of Cardiovascular Pharmacology?
Who is the publisher of Journal of Cardiovascular Pharmacology?
